Latest Articles

Publication Date
Genetically identification of endometriosis and cancers risk in women through a two-sample Mendelian randomization study | Scientific Reports - Nature.com

Genetically identification of endometriosis and cancers risk in women through a two-sample Mendelian randomization study | Scientific Reports Nature.com

Published: April 10, 2024, 7 a.m.
The prognostic value of MEK pathway–associated estrogen receptor signaling activity for female cancers - Nature.com

The prognostic value of MEK pathway–associated estrogen receptor signaling activity for female cancers Nature.com

Published: April 6, 2024, 7 a.m.
Trastuzumab Deruxtecan Proves Active in HER2-Expressing Gynecologic Cancers - Cancer Therapy Advisor

Trastuzumab Deruxtecan Proves Active in HER2-Expressing Gynecologic Cancers Cancer Therapy Advisor

Published: March 17, 2024, 7 a.m.
Melatonin: Current evidence on protective and therapeutic roles in gynecological diseases.

Melatonin, a potent antioxidant and free radical scavenger, has been demonstrated to be effective in gynecological conditions and female reproductive cancers. This review consolidates the accumulating evidence on melatonin's multifaceted …

Published: March 11, 2024, midnight
A common allele increases endometrial Wnt4 expression, with antagonistic implications for pregnancy, reproductive cancers, and endometriosis - Nature.com

A common allele increases endometrial Wnt4 expression, with antagonistic implications for pregnancy, reproductive cancers, and endometriosis Nature.com

Published: Feb. 12, 2024, 8 a.m.
World Cancer Day 2024: 5 common cancers in women beyond cervical cancer - Hindustan Times

World Cancer Day 2024: 5 common cancers in women beyond cervical cancer Hindustan Times

Published: Feb. 4, 2024, 8 a.m.
Gynecologic cancers: Early detection and understanding symptoms can save lives - University of Alabama at Birmingham

Gynecologic cancers: Early detection and understanding symptoms can save lives University of Alabama at Birmingham

Published: Jan. 26, 2024, 8 a.m.
SMARCA4 loss irrelevant for ARID1A mutated ovarian clear cell carcinoma: A case report.

Clear cell carcinomas are rare and relatively chemo-insensitive ovarian cancers with a characteristic molecular pathogenesis. Alterations in ARID1A, a component of the multiprotein chromatin remodeling complex SWI/SNF, are likely early …

Published: Nov. 14, 2023, midnight
Endometriosis Is Undervalued: A Call to Action.

Endometriosis is an inflammatory chronic pain condition caused by uterine tissue growing outside of the uterus that afflicts at least 11% of women (and people assigned female at birth) worldwide. …

Published: May 10, 2022, midnight
A clearer view on ovarian clear cell carcinoma.

Ovarian clear cell carcinoma (OCCC) is a less common subtype accounting for approximately 5% of all epithelial ovarian cancers (EOCs). Clinical experience and research findings confirm the remarkable differences in …

Published: Aug. 17, 2021, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!